NEW YORK (GenomeWeb) – Oncology diagnostics firm Cancer Genetics today announced that its CLIA-certified, CAP-accredited laboratory has received the California Clinical Laboratory License, which will allow the company to perform its oncology testing services on patient samples from the state of California.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.